x

Search for a clinical trial

* (*) mandatory field

75 Result(s)

Sort by

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member =

National clinical trial(s)

AUSTRIA

SALZBURG
SALZBURG

Recruiting trial
Ongoing trial
Phase 3 multi-center randomized study to compare efficacy and safety of romidepsin-CHOP (Ro-CHOP) versus CHOP in patients with previously untreated peripheral T-cell lymphoma - AT
Salzburger Landeskliniken (SALK) / Paracelsus Med. Privatuniversität (PMU)
Universitätsklinik für Innere Medizin III

AUSTRIA

TIROL
INNSBRUCK

GERMANY

Baden-Württemberg
MANNHEIM

Recruiting trial
Ongoing trial
Phase IIA Study on Therapy in Patients With Cutaneous T Cell Lymphoma - DE
Universitätsmedizin Mannheim
Klinik für Dermatologie, Venerologie und Allergologie

UNITED KINGDOM

Greater Manchester
MANCHESTER

FRANCE

ILE-DE-FRANCE
PARIS

FRANCE

OCCITANIE
MONTPELLIER

Study to Evaluate the Safety and Efficacy of Adeno-IFN Gamma in Cutaneous B-Cell Lymphoma (Phase II) - FR
CHRU de Montpellier - Hôpital Gui de Chauliac
Département d'hématologie clinique

SWITZERLAND

Suisse Alémanique
ZÜRICH

FRANCE

BOURGOGNE-FRANCHE-COMTE
BESANÇON

FRANCE

ILE-DE-FRANCE
PARIS

Treatment of aggressive lymphoma in adults: NHL 98
CHU Paris-GH St-Louis Lariboisière F.Widal - Hôpital Saint-Louis
Institut Universitaire d'Hématologie

FRANCE

PAYS DE LA LOIRE
NANTES

FRANCE

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

Intensive sequential chemotheray in non hodgkin lymphoma (NLH) of patients suffering from HIV- CIS VIH 02 (Phase IV) - trial stopped -
CLCC Institut Paoli Calmettes
Unité d'Evaluation Thérapeutique en Onco-Hématologie (ETHO)

GERMANY

Baden-Württemberg
TÜBINGEN

Pegfilgrastim vs. filgrastim - comparison of mobilized blood stem cells in patients with Non-Hodgkin lymphoma (Phase II) - DE
Department für Innere Medizin - Medizinische Universitätsklinik Tübingen
Innere Medizin II - Onkologie, Hämatologie, Klinische Immunologie, Rheumatologie und Pulmologie

ITALY

EMILIA ROMAGNA
BOLOGNA

Recruiting trial
Ongoing trial
Study of Lenalidomide(Revlimid) Plus Rituximab (Revlirit Regimen) in Elderly Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Policlinico S. Orsola-Malpighi - Area S. Orsola
Dipartimento di Ematologia e Scienze Oncologiche

NETHERLANDS

Gelderland
NIJMEGEN

NETHERLANDS

Noord-Holland
AMSTERDAM

Ongoing trial
Low dose radiotherapy (2x 2 Gy)in low grade Non-Hodgkin lymphomas
Het Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis
Groep Tumorbiologie

NETHERLANDS

Zuid-Holland
ROTTERDAM

SPAIN

Cataluña
ESPLUGUES DE LLOBREGAT

UNITED KINGDOM

Greater Manchester
NOT YET IDENTIFIED - UK

UNITED KINGDOM

Greater Manchester
NOT YET IDENTIFIED - UK

Multinational clinical trial(s)